Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-19

Clinical Trial Update: Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oral fosfomycin to oral levofloxacin for complicated urinary syndromes has been terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosfomycin (Fosfomycin)
  • Levofloxacin (Levofloxacin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Urinary Tract Infection | Phase 4 | Status: TERMINATED | Results posted: 2020-12-19